Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO

We just turned the page on 2018, with many Big Pharma companies having planned to exit the consumer health business, but Takeda doesn’t intend to join the party even though it’s in pressing need of money after a $58 billion acquisition.